A. Çamtosun, "Are neutrophillymphocyte and platelet lymphocyte ratios valuable in predicting prostate cancer?," EUROPEAN UROLOGY, SUPPLEMENTS , vol.11, no.17, pp.39, 2018
Çamtosun, A. 2018. Are neutrophillymphocyte and platelet lymphocyte ratios valuable in predicting prostate cancer?. EUROPEAN UROLOGY, SUPPLEMENTS , vol.11, no.17 , 39.
Çamtosun, A., (2018). Are neutrophillymphocyte and platelet lymphocyte ratios valuable in predicting prostate cancer?. EUROPEAN UROLOGY, SUPPLEMENTS , vol.11, no.17, 39.
Çamtosun, AHMET. "Are neutrophillymphocyte and platelet lymphocyte ratios valuable in predicting prostate cancer?," EUROPEAN UROLOGY, SUPPLEMENTS , vol.11, no.17, 39, 2018
Çamtosun, AHMET. "Are neutrophillymphocyte and platelet lymphocyte ratios valuable in predicting prostate cancer?." EUROPEAN UROLOGY, SUPPLEMENTS , vol.11, no.17, pp.39, 2018
Çamtosun, A. (2018) . "Are neutrophillymphocyte and platelet lymphocyte ratios valuable in predicting prostate cancer?." EUROPEAN UROLOGY, SUPPLEMENTS , vol.11, no.17, p.39.
@article{article, author={AHMET ÇAMTOSUN}, title={Are neutrophillymphocyte and platelet lymphocyte ratios valuable in predicting prostate cancer?}, journal={EUROPEAN UROLOGY, SUPPLEMENTS}, year=2018, pages={39} }